NEWS IN BRIEF
Sagent acquires US facility with an eye on future biosimilar products
Sagent purchases Xellia’s FDA-approved site in North Carolina, which has capabilities to manufacture both small molecule and biologic products.
Archives for March 12, 2019
Fujifilm continues ‘aggressive’ expansion with $890m site purchase
Fujifilm continues investment in its manufacturing capabilities through the acquisition of a large-scale biologics site from Biogen.